SARS-CoV-2 infection increases risk of acute kidney injury in a bimodal age distribution
Erica C. Bjornstad(Children's of Alabama), Robert Glavinić(University of Alabama at Birmingham), Valerie Banner‐Goodspeed(Beth Israel Deaconess Medical Center), Dominko Carev(University of Alabama at Birmingham), Tanja Kovačević(University of Split), Nancy M. Tofil(Robert Wood Johnson University Hospital), Allan J. Walkey(Boston University), Philippe Clevenbergh, Rolando Claure‐Del Granado(Universidad Mayor de San Simón), Tatjana Ćatipović Ardalić(University of Alabama at Birmingham), Pierre Henin(University of Alabama at Birmingham), Danijel Knežević(University of Alabama at Birmingham), Vishakha K. Kumar(Society of Critical Care Medicine), Shina Menon(Seattle Children's Hospital), Branka Polić(University of Alabama at Birmingham), Maria F. Iturricha-Cáceres(University of Alabama at Birmingham), Gary Cutter(Epilepsy Foundation), Karen Boman(Society of Critical Care Medicine), Vikas Bansal(Mayo Clinic in Florida), Devang Sanghavi(WinnMed), Mayank Sharma(Jacksonville College), Yasir Tarabichi(MetroHealth), Lynn Retford(Society of Critical Care Medicine), Katja M. Gist(Children's Hospital Colorado), Jean-Baptiste Mesland(Cliniques Universitaires Saint-Luc), Joško Markić(Klinički Bolnički Centar Split), Oscar Y. Gavidia, Neha Deo(Mayo Clinic), A Gérard(University of Alabama at Birmingham), Amy B. Christie(Navicent Health), Pramod Guru(Jacksonville College), Girish Vadgaonkar, Felipe Pachon(University of Alabama at Birmingham), Ognjen Gajic(Mayo Clinic), José A. Mercado(University of Alabama at Birmingham), Hélène Petre(University of Alabama at Birmingham), Dragana Markotić(University of Alabama at Birmingham), Isabelle Buelens(University of Alabama at Birmingham), Esdenka Vega-Terrazas(University of Alabama at Birmingham), Isabella Aldana(University of Alabama at Birmingham), Ivana Bošnjak(University of Alabama at Birmingham), Yeimy A. Sanchez(University of Alabama at Birmingham), Catherine A. St. Hill(Abbott Northwestern Hospital), Ivo Ivić(University of Alabama at Birmingham), Surapaneni Krishna Mohan(Panimalar Medical College Hospital & Research Institute), Scott House(University of Alabama at Birmingham)
Cited by 10
Related Papers
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
|The Lancet|2019|722